Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-007406

Chief Executive Officer sold 9,500 shares at $0.67 ($6,369)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-23 Sale : show line 1 in the form −9,500 $0.67 $6,369 863,742 D
Open-market sales · 9,500 sh · avg $0.67 · $6,369
Loading xslF345X05/ownership.xml…